^
Association details:
Biomarker:ER negative
Cancer:Breast Cancer
Drug:anastrozole (Aromatase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
Published date:
12/13/2018
Excerpt:
ARIMIDEX is an aromatase inhibitor indicated for:...Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to ARIMIDEX.